Results 291 to 300 of about 769,731 (345)

NET‐DNA Activates the ANXA2/TMEM215/BiP Axis to Promote Mitophagy‐Mediated Anoikis Resistance in Endometriosis

Advanced Science, EarlyView.
NET‐DNA is enriched during early endometriotic lesion establishment and drives anoikis resistance by promoting an ANXA2–TMEM215–BiP axis. This pathway strengthens ER–mitochondria contacts, enhances PINK1/Parkin‐associated mitophagy, preserves mitochondrial homeostasis, and supports ectopic stromal cell survival, thereby facilitating lesion persistence ...
Honglin Wang, Yanling Gou, Huiyan Zhang, Hongli Wang, Beidi Wang, Jinming Liu, Yingying Cao, Ruru Bai, Yuxin Zhao, Xu Han, Chao Feng, Xin Huang, Zongfeng Zhang   +12 more
wiley   +1 more source

Distinguishing the significance of blood microbes in epithelial ovarian cancer. [PDF]

Gut Microbes Rep
Mahoney DE, Chalise P, Pei D, Griffard-Smith R, Home T, Pathak HB, Umar S, Godwin AK.   +7 more
europepmc   +1 more source

Natural Resistance to Ovarian Hyperstimulation Syndrome in Estrildid Finches Reveals Macrophage GPR183 as a Potential Therapeutic Target

Advanced Science, EarlyView.
Ovarian macrophage depletion reverses OHSS resistance in estrildid finches and exacerbates OHSS symptoms in rats. Activating macrophage GPR183 alleviates OHSS by reducing pro‐inflammatory factors, increasing immunomodulatory molecules, remodeling CD44/SDC4‐mediated communication, and restoring immune homeostasis.
Xiaofei Yan, Yongjie Huang, Jiabao Yang, Su Ma, Songsong Liu, Xuan Huang, Juergen Brosius, Huaping Zheng, Bing Yao, Li Chen, Shanshan Lai, Cheng Deng   +11 more
wiley   +1 more source

TRIP13 identified by WGCNA as a progression-related and prognostic biomarker in ovarian cancer. [PDF]

Front Med (Lausanne)
Zhang H, Zhang M, Hu Y, He Y.
europepmc   +1 more source

Molecular profile and targeted therapies for ovarian clear cell ovarian cancer. [PDF]

Ther Adv Med Oncol
Sachdeva M, Tan DSP.
europepmc   +1 more source

Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy.

JAMA Netw Open
Sowamber R, Mei AJ, Kaur P, McLeod J, McKay E, Lukey A, Bakkum-Gamez J, Buza N, Cohen PA, Devins K, Farrell R, Garcia C, Gilks B, Goode E, Hodgson A, Howitt B, Hui P, Huvila J, Karnezis A, Keyhanian K, Kinloch M, Köbel M, Kommoss FKF, Kushi L, Kwon JS, Long-Roche K, Malpica A, McAlpine JN, Miller D, Oliva E, Palicelli A, Paliga A, Parra-Herran C, Pearce CL, Perera S, Piek JM, Qiu H, Rabban J, Rome R, Steenbeek M, Stone R, Talhouk A, Tischer KM, Trabert B, Webb PM, Zalcberg JR, Huntsman DG, Hanley GE.   +47 more
europepmc   +1 more source

Potential role of microbiota in ovarian cancer treatment. [PDF]

Arch Med Sci
Englert-Golon M, Sajdak S, Plagens-Rotman KM, Merks P, Kędzia W, Szwed A, Durda-Masny M.   +6 more
europepmc   +1 more source

Subcellular Stress Markers in Epithelial Ovarian Cancer. [PDF]

Int J Mol Sci
Wappler-Guzzetta EA, Margittai E, Veszelyi K, Pickard S, Merwin C, Molvarec A, Czegle I.   +6 more
europepmc   +1 more source

Dynamic changes of the immune microenvironment in ovarian cancer following neoadjuvant chemotherapy. [PDF]

Cell Death Discov
Wu M, Lv F, Jin Y, Wang S, Meng L, Tong J, Zou R.   +6 more
europepmc   +1 more source